Moderna now leads the market as the worst performer of the month, losing 33% in January, with Netflix coming close behind with a 29% loss. Moderna gained back 6% after it announced its Covid-19 vaccine had received full approval from the Food and Drug Administration, becoming the second messenger RNA-based pharmaceutical product to receive FDA approval. EPAM, Etsy, and Teradyne have all lost around 28%. Read More...
Moderna now leads the market as the worst performer of the month, losing 33% in January, with Netflix coming close behind with a 29% loss. Moderna gained back 6% after it announced its Covid-19 vaccine had received full approval from the Food and Drug Administration, becoming the second messenger RNA-based pharmaceutical product to receive FDA approval. EPAM, Etsy, and Teradyne have all lost around 28%.
Add Comment